Skip to main content
. 2015 Dec 22;5:18789. doi: 10.1038/srep18789

Figure 4. Effects of the combination treatment of paclitaxel and nobiletin on ABCB1 expression and AKT/ERK/Nrf2 pathway.

Figure 4

(A) The MDR1 mRNA level was determined by RT-PCR in A2780/T cells or A2780 cells. Combination treatment of paclitaxel and nobiletin did not influence P-gp expression levels, but unregulated the p53 expression (B) and reduced the expression level of Nrf2 (C) as well as the phosphorylation of AKT/ERK (B) by Western blot assay.